API Product Detail
Home API Dolutegravir CS-O-00218

Dolutegravir

Chemical Properties and Information

Product Code: CS-O-00218 API
Dolutegravir
API Family
Dolutegravir
Product Code
CS-O-00218

Dolutegravir

Dolutegravir API
Stock Status: In Stock
Live

CAT No.
CS-O-00218
CAS No.
1051375-16-6
Molecular Formula
C20H19F2N3O5
Molecular Weight
419.38
Login to view price
There is no hazardous surcharge associated with this product.
There is no packaging charge associated with this product.
For Research Purposes only. Not for Personal use.
All compounds supplied are strictly intended for laboratory, research, analytical, and scientific use only. They are not meant for human consumption, therapeutic use, or any form of clinical application.
CAS No.
1051375-16-6
Product Code
CS-O-00218
M.F.
C20H19F2N3O5
M.W.
419.38
Smiles
O=C1C=2N(C[C@]3(N1[C@H](C)CCO3)[H])C=C(C(NCC4=C(F)C=C(F)C=C4)=O)C(=O)C2O
Category
API
API Family
Dolutegravir
Storage Condition
Store at refrigerator (2-8°C) for long term storage
IUPAC Name
(4R,12aS)-N-(2,4-difluorobenzyl)-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide
References
"Kobayashi; M, et al, Antimcrob Agentschemother,; 55; 813 (2011); Garrido;c, et al,: Antiviral; Res,; 90; 164 (2011); Lenz; Jcc, et al,: Exp, Opin, Invest, Drugs; 20; 537 (2011);"
Synonyms
(4R,12aS)-N-[(2,4-Difluorophenyl)methyl]-3,4,6,8,12,12a-hexahydro-7-hydroxy-4-methyl-6,8-dioxo-2H-pyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide
Application Notes
Dolutegravir is a second generation HIV-1 integrase strand transfer inhibitor. Dolutegravir is currently in Phase III clinical trials for the treatment of HIV infection. Dolutegravir has been shown to potently inhibit HIV replication in cells such as peri
Purity by HPLC
Not less than 95%
Hazard Compound
Refer MSDS for accurate information.
Overview
Dolutegravir is a second generation HIV-1 integrase strand transfer inhibitor. Dolutegravir is currently in Phase III clinical trials for the treatment of HIV infection. Dolutegravir has been shown to potently inhibit HIV replication in cells such as peri
Downloading MSDS…
Quick Enquiry
Tell us what you need
Quote Basket
Selected RFQ Items
Your RFQ basket is empty. Add a product block or copy a guided requirement here.